Antibodies
31 May 2009
Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer30 May 2009
ImmunoGen, Inc. Announces Encouraging Trastuzumab-DM1 Phase II Clinical Findings Presented at ASCO30 May 2009
Pfizer Data Identify Certain Lung Cancer Patients Who May Benefit from Treatment with Figitumumab30 May 2009
Immunomedics Reports Updated Results of Milatuzumab in Dose-Escalation Study for Multiple MyelomaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports